help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, K.-h.
Right arrow Articles by Wu shen-liang chen, Y.-h.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, K.-h.
Right arrow Articles by Wu shen-liang chen, Y.-h.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LIOTHYRONINE
Medline Plus Health Information
*Liver Cancer
Endocrinology Vol. 142, No. 2 653-662
Copyright © 2001 by The Endocrine Society


ARTICLES

Impaired Interaction of Mutant Thyroid Hormone Receptors Associated with Human Hepatocellular Carcinoma with Transcriptional Coregulators1

Kwang-huei Lin and Yi-hsin Wu shen-liang chen

Department of Biochemistry, Chang-Gung University, Taoyuan, Taiwan 333, Republic of China

Address all correspondence and requests for reprints to: Kwang-Huei Lin, Department of Biochemistry, Chang-Gung University, 259 Wen-hwa 1 Road, Taoyuan, Taiwan, Republic of China. E-mail: khlin{at}mail.cgu.edu.tw

Thyroid hormone (T3) exerts its many biological activities through interaction with specific nuclear receptors (TRs) that function as ligand-dependent transcription factors at genes that contain a thyroid hormone response element (TRE). Mutant TRs have been detected in human hepatocellular carcinoma cell lines and tissue, but their contribution to carcinogenesis has remained unclear. The interaction of four such mutant TRs (J7-TR{alpha}1, J7-TRß1, H-TR{alpha}1, and L-TR{alpha}1) with transcriptional coregulators has now been investigated. With the exception of J7-TR{alpha}1, which in the absence of T3 exhibited transcriptional silencing activity with a TRE-reporter gene construct in transfected cells, the mutant TRs had little effect (compared with that of wild-type receptors) on transcriptional activity of the reporter gene in the absence or presence of T3, of the transcriptional corepressors SMRT, NCoR or of the transcriptional coactivator SRC. Electrophoretic mobility-shift assays revealed that, in the presence of T3, the J7-TRß1 mutant did not interact with SRC, whereas J7-TR{alpha}1 and H-TR{alpha}1 exhibited reduced abilities to associate with this coactivator and L-TR{alpha}1 showed an ability to interact with SRC similar to that of wild-type TR{alpha}1. The dominant negative activity of the mutant TRs in transfected cells appeared inversely related to the ability of the receptors to interact with SRC. Whereas J7-TRß1, H-TR{alpha}1, and L-TR{alpha}1 did not interact with SMRT, and NCoR. J7-TR{alpha}1 bind to corepressors but failed to dissociate from them in the presence of T3. These aberrant interactions between the mutant TRs and transcriptional coregulators may contribute to the highly variable clinical characteristics of human hepatocellular carcinoma.




This article has been cited by other articles:


Home page
EndocrinologyHome page
S. L. Chen, Y. J. Chang, Y. H. Wu, and K. H. Lin
Mitogen-Activated Protein Kinases Potentiate Thyroid Hormone Receptor Transcriptional Activity by Stabilizing Its Protein
Endocrinology, April 1, 2003; 144(4): 1407 - 1419.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Kaneshige, H. Suzuki, K. Kaneshige, J. Cheng, H. Wimbrow, C. Barlow, M. C. Willingham, and S.-y. Cheng
A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice
PNAS, November 29, 2001; (2001) 261565798.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Kaneshige, H. Suzuki, K. Kaneshige, J. Cheng, H. Wimbrow, C. Barlow, M. C. Willingham, and S.-y. Cheng
A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice
PNAS, December 18, 2001; 98(26): 15095 - 15100.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society